Detection of respiratory syncytial virus (RSV) at birth in a newborn with respiratory distress

Pediatric Pulmonology

Volumn 52, Issue 10, 2017, Pages E81-E84

  Manti, Sara ^a   Cuppari, Caterina ^a   Lanzafame, Angela ^b   Salpietro, Carmelo ^a   Betta, Pasqua ^b   Leonardi, Salvatore ^b   Perez, Miriam K ^c   Piedimonte, Giovanni ^c  

^a UNIVERSITY OF MESSINA   (Italy)

^b UNIVERSITY OF CATANIA   (Italy)

^c LERNER RESEARCH INSTITUTE   (United States)

Author keywords

asthma early wheeze; critical care; developmental biology; infections: pneumonia, TB, viral; neonatal pulmonary medicine

Indexed keywords

IMMUNOGLOBULIN G ANTIBODY; IMMUNOGLOBULIN M ANTIBODY;

ANTIBIOTIC THERAPY; ANTIBODY TITER; APGAR SCORE; ARTERIAL GAS; ARTICLE; BIRTH WEIGHT; CASE REPORT; CESAREAN SECTION; CLINICAL ARTICLE; CLINICAL EXAMINATION; CRACKLE; EMERGENCY SURGERY; ENTERIC FEEDING; FAMILY HISTORY; GESTATIONAL AGE; HOSPITAL DISCHARGE; HUMAN; HUMAN RESPIRATORY SYNCYTIAL VIRUS; MALE; MEDICAL HISTORY; NEONATAL INTENSIVE CARE UNIT; NEWBORN; NEWBORN CARE; OXYGEN SATURATION; PHYSICAL EXAMINATION; POSITIVE END EXPIRATORY PRESSURE; PRIORITY JOURNAL; REAL TIME POLYMERASE CHAIN REACTION; RESPIRATORY DISTRESS SYNDROME; RESPIRATORY SYNCYTIAL VIRUS INFECTION; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; SCREENING; SEROLOGY; TACHYCARDIA; TACHYPNEA; THORAX RADIOGRAPHY; TREATMENT DURATION; TREATMENT INDICATION; VIRUS DETECTION; VERTICAL TRANSMISSION;

HUMANS; INFANT, NEWBORN; INFECTIOUS DISEASE TRANSMISSION, VERTICAL; MALE; RESPIRATORY SYNCYTIAL VIRUS INFECTIONS; RESPIRATORY SYNCYTIAL VIRUS, HUMAN;

EID: 85027490988     PISSN: 87556863     EISSN: 10990496     Source Type: Journal    
DOI: 10.1002/ppul.23775     Document Type: Article

References (29)

1. Wright M, Piedimonte G. Respiratory syncytial virus prevention and therapy: past, present, and future. Pediatr Pulmonol. 2011; 46:324–347.
2. Nair H, Nokes DJ, Gessner BD, et al. Global burden of acute lower respiratory infections due to respiratory syncytial virus in young children: a systematic review and meta- analysis. Lancet. 2010; 375:1545–1555.
3. Bruhn FW, Yeager AS. Respiratory syncytial virus in early infancy: circulating antibody and the severity of infection. Am J Dis Child. 1977; 131:145–148.
4. Bohmwald K, Espinoza JA, González PA, Bueno SM, Riedel CA, Kalergis AM. Central nervous system alterations caused by infection with the human respiratory syncytial virus. Rev Med Virol. 2014; 24:407–419.
5. Eisenhut M. Extrapulmonary manifestations of severe respiratory syncytial virus infection—a systematic review. 2006; 10:R107.
6. Rezaee F, Gibson LF, Piktel D, Othumpangat S, Piedimonte G. Respiratory syncytial virus infection in human bone marrow stromal cells. Am J Respir Cell Mol Biol. 2011; 45:277–286.
7. Brown PM, Harford TJ, Agrawal V, et al. Prenatal exposure to respiratory syncytial virus alters postnatal immunity and airway smooth muscle contractility during early-life reinfections. PLoS ONE. 2017; 12:e0168786.
8. Piedimonte G, Perez MK. Alternative mechanisms for respiratory syncytial virus (RSV) infection and persistence: could RSV be transmitted through the placenta and persist into developing fetal lungs? Curr Opin Pharmacol. 2014; 16:82–88.
9. Piedimonte G, Walton C, Samsell L. Vertical transmission of respiratory syncytial virus modulates pre- and postnatal innervation and reactivity of rat airways. PLoS ONE. 2013; 8:e61309.
10. Ogra PL. Respiratory syncytial virus: the virus, the disease and the immune response. Paediatr Respir Rev. 2004; 5:S119–S126.
11. Hall CB, Weinberg GA, Iwane MK, et al. The burden of respiratory syncytial virus infection in young children. N Engl J Med. 2009; 360:588–598.
12. Legg J, P, Jones CA, Warner JA, Johnston SL, Warner JO. A hypothesis: antenatal sensitisation to respiratory syncytial virus in viral bronchiolitis. Arch Dis Child. 2002; 86:431–433.
13. Munoz FM, Piedra PA, Glezen WP. Safety and immunogenicity of respiratory syncytial virus purified fusion protein 2 vaccine in pregnant women. Vaccine. 2003; 21:3465–3467.
14. Fjaerli HO, Bukholm G, Skjaeret C, Holden M, Nakstad B. Cord blood gene expression in infants hospitalized with respiratory syncytial virus bronchiolitis. J Infect Dis. 2007; 196:394–404.
15. Glezen WP, Paredes A, Allison JE, Taber LH, Frank AL. Risk of respiratory syncytial virus infection for infants from low-income families in relationship to age, sex, ethnic group and maternal antibody level. J Pediatr. 1991; 98:708–715.
16. Scuri M, Samsell L, Piedimonte G. The role of neurotrophins in inflammation and allergy. Inflamm Allergy Drug Targets. 2010; 9:173–180.
17. Boppana SB, Rivera LB, Fowler KB, Mach M, Britt WJ. Intrauterine transmission of cytomegalovirus to infants of women with preconceptional immunity. N Engl J Med. 2001; 344:1366–1371.
18. Swasdipan S, McGowan M, Phillips N, Bielefeldt-Ohmann H. Pathogenesis of transplacental virus infection: pestivirus replication in the placenta and fetus following respiratory infection. Microb Pathog. 2002; 32:49–60.
19. Mims CA. Vertical transmission of viruses. Microbiol Rev. 1981; 45:267–286.
20. Rohwedder A, Keminer O, Forster J, Schneider K, Schneider E, Werchau H. Detection of respiratory syncytial virus RNA in blood of neonates by polymerase chain reaction. J Med Virol. 1998; 54:320–327.
21. Avrech OM, Samra Z, Lazarovich Z, Caspi E, Jacobovich A, Sompolinsky D. Efficacy of the placental barrier for immunoglobulins: correlations between maternal, paternal and fetal immunoglobulin levels. Int Arch Allergy Immunol. 1994; 103:160–165.
22. Cederqvist LL, Merkatz IR, Litwin SD. Fetal immunoglobulin synthesis following maternal immunosuppression. Am J Obstet Gynecol. 1977; 129:687–690.
23. Cederqvist LL, Ewool LC, Litwin SD. The effect of fetal age, birth weight, and sex on cord blood immunoglobulin values. Am J Obstet Gynecol. 1978; 131:520–525.
24. Cederqvist LL, Litwin SD. Production of alpha 1 and alpha 2 immunoglobulin heavy chains during fetal life. J Immunol. 1974; 112:1605–1608.
25. Malek A, Sager R, Kuhn P, Nicolaides KH, Schneider H. Evolution of maternofetal transport of immunoglobulins during human pregnancy. Am J Reprod Immunol. 1996; 36:248–255.
26. Malek A, Sager R, Schneider H. Transport of proteins across the human placenta. Am J Reprod Immunol. 1998; 40:347–351.
27. Ueda H, Nakanishi A, Ichijo M. Immunoglobulins in newborns, particularly in term SFD infants. Tohoku J Exp Med. 1980; 132:31–35.
28. Malek A. Ex vivo human placenta models: transport of immunoglobulin G and its subclasses. Vaccine. 2003; 21:3362–3364.
29. Hanson LA, Silfverdal SA. The mother's immune system is a balanced threat to the foetus, turning to protection of the neonate. Acta Paediatr. 2009; 98:221–228.